Use of atypical antipsychotic medications in later life

Tarek Rajji, Benoit H. Mulsant, Hiroyuki Uchida, David Mamo

Research output: Contribution to journalArticle

Abstract

Antipsychotics are increasingly being prescribed to older patients for the management of a variety of neuropsychiatric conditions. Available evidence supports the use of second-generation antipsychotics (SGAs) when treating these conditions. However, given their modest clinical effect for certain conditions (e.g., behavioural and psychological symptoms of dementia), their adverse effects, and their safety profile, a careful analysis of their risks and benefits is needed before initiating treatment with an SGA for an older patient. Among SGAs, choice of medication should be guided by their respective clinical indications and adverse effect profile, with use of lower initial and target doses (compared to younger adults) and periodic reviews of whether or not their continued use is warranted.

Original languageEnglish
Pages (from-to)578-587
Number of pages10
JournalGeriatrics and Aging
Volume10
Issue number9
Publication statusPublished - 2007 Oct
Externally publishedYes

Fingerprint

Antipsychotic Agents
Behavioral Symptoms
Dementia
Young Adult
Psychology
Safety
Therapeutics

Keywords

  • Antipsychotics
  • Delirium
  • Dementia
  • Older adults
  • Schizophrenia

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

Rajji, T., Mulsant, B. H., Uchida, H., & Mamo, D. (2007). Use of atypical antipsychotic medications in later life. Geriatrics and Aging, 10(9), 578-587.

Use of atypical antipsychotic medications in later life. / Rajji, Tarek; Mulsant, Benoit H.; Uchida, Hiroyuki; Mamo, David.

In: Geriatrics and Aging, Vol. 10, No. 9, 10.2007, p. 578-587.

Research output: Contribution to journalArticle

Rajji, T, Mulsant, BH, Uchida, H & Mamo, D 2007, 'Use of atypical antipsychotic medications in later life', Geriatrics and Aging, vol. 10, no. 9, pp. 578-587.
Rajji, Tarek ; Mulsant, Benoit H. ; Uchida, Hiroyuki ; Mamo, David. / Use of atypical antipsychotic medications in later life. In: Geriatrics and Aging. 2007 ; Vol. 10, No. 9. pp. 578-587.
@article{88c8fe4cd54f48fcb40d50fc2d367ba1,
title = "Use of atypical antipsychotic medications in later life",
abstract = "Antipsychotics are increasingly being prescribed to older patients for the management of a variety of neuropsychiatric conditions. Available evidence supports the use of second-generation antipsychotics (SGAs) when treating these conditions. However, given their modest clinical effect for certain conditions (e.g., behavioural and psychological symptoms of dementia), their adverse effects, and their safety profile, a careful analysis of their risks and benefits is needed before initiating treatment with an SGA for an older patient. Among SGAs, choice of medication should be guided by their respective clinical indications and adverse effect profile, with use of lower initial and target doses (compared to younger adults) and periodic reviews of whether or not their continued use is warranted.",
keywords = "Antipsychotics, Delirium, Dementia, Older adults, Schizophrenia",
author = "Tarek Rajji and Mulsant, {Benoit H.} and Hiroyuki Uchida and David Mamo",
year = "2007",
month = "10",
language = "English",
volume = "10",
pages = "578--587",
journal = "Geriatrics and Aging",
issn = "1488-8408",
publisher = "Geriatrics and Aging",
number = "9",

}

TY - JOUR

T1 - Use of atypical antipsychotic medications in later life

AU - Rajji, Tarek

AU - Mulsant, Benoit H.

AU - Uchida, Hiroyuki

AU - Mamo, David

PY - 2007/10

Y1 - 2007/10

N2 - Antipsychotics are increasingly being prescribed to older patients for the management of a variety of neuropsychiatric conditions. Available evidence supports the use of second-generation antipsychotics (SGAs) when treating these conditions. However, given their modest clinical effect for certain conditions (e.g., behavioural and psychological symptoms of dementia), their adverse effects, and their safety profile, a careful analysis of their risks and benefits is needed before initiating treatment with an SGA for an older patient. Among SGAs, choice of medication should be guided by their respective clinical indications and adverse effect profile, with use of lower initial and target doses (compared to younger adults) and periodic reviews of whether or not their continued use is warranted.

AB - Antipsychotics are increasingly being prescribed to older patients for the management of a variety of neuropsychiatric conditions. Available evidence supports the use of second-generation antipsychotics (SGAs) when treating these conditions. However, given their modest clinical effect for certain conditions (e.g., behavioural and psychological symptoms of dementia), their adverse effects, and their safety profile, a careful analysis of their risks and benefits is needed before initiating treatment with an SGA for an older patient. Among SGAs, choice of medication should be guided by their respective clinical indications and adverse effect profile, with use of lower initial and target doses (compared to younger adults) and periodic reviews of whether or not their continued use is warranted.

KW - Antipsychotics

KW - Delirium

KW - Dementia

KW - Older adults

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=36049004315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36049004315&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 578

EP - 587

JO - Geriatrics and Aging

JF - Geriatrics and Aging

SN - 1488-8408

IS - 9

ER -